Last Updated: November 18, 2026

Copper - Generic Drug Details

« Back to Dashboard


What are the generic sources for copper and what is the scope of freedom to operate?

Copper is the generic ingredient in six branded drugs marketed by Gd Searle Llc, Sebela Womens Hlth, Coopersurgical, Curium, and Sentynl Theraps Inc, and is included in six NDAs. There are eighteen patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Two suppliers are listed for this compound.

Summary for Copper
International Patents:30
US Patents:18
Tradenames:6
Applicants:5
NDAs:6
Finished Product Suppliers / Packagers: 2
Raw Ingredient (Bulk) Api Vendors: 2869
Clinical Trials: 176
What excipients (inactive ingredients) are in Copper?Copper excipients list
DailyMed Link:Copper at DailyMed
Recent Clinical Trials for Copper

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Old Dominion UniversityPHASE1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)PHASE1
ZabBio Inc.PHASE1

See all Copper clinical trials

Medical Subject Heading (MeSH) Categories for Copper

US Patents and Regulatory Information for Copper

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Coopersurgical PARAGARD T 380A copper SYSTEM;INTRAUTERINE 018680-001 Nov 15, 1984 RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Curium DETECTNET copper cu-64 dotatate SOLUTION;INTRAVENOUS 213227-001 Sep 3, 2020 RX Yes Yes 12,102,696 ⤷  Start Trial Y ⤷  Start Trial
Sebela Womens Hlth MIUDELLA copper SYSTEM;INTRAUTERINE 218201-001 Feb 24, 2025 RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Sentynl Theraps Inc ZYCUBO copper histidinate POWDER;SUBCUTANEOUS 211241-001 Jan 12, 2026 RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Copper

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Gd Searle Llc CU-7 copper INTRAUTERINE DEVICE;INTRAUTERINE 017408-001 Approved Prior to Jan 1, 1982 3,563,235 ⤷  Start Trial
Gd Searle Llc CU-7 copper INTRAUTERINE DEVICE;INTRAUTERINE 017408-001 Approved Prior to Jan 1, 1982 4,040,417 ⤷  Start Trial
Gd Searle Llc CU-7 copper INTRAUTERINE DEVICE;INTRAUTERINE 017408-001 Approved Prior to Jan 1, 1982 RE28399 ⤷  Start Trial
Gd Searle Llc TATUM-T copper INTRAUTERINE DEVICE;INTRAUTERINE 018205-001 Approved Prior to Jan 1, 1982 3,803,308 ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for Copper

Country Patent Number Title Estimated Expiration
Australia 2014334816 Intrauterine device with retrieval thread ⤷  Start Trial
Australia 2019200369 Intrauterine device with retrieval thread ⤷  Start Trial
Brazil 112016008594 Sistema contraceptivo intrauterino ⤷  Start Trial
Canada 2926933 DISPOSITIF INTRA-UTERIN AVEC FIL D'EXTRACTION (INTRAUTERINE DEVICE WITH RETRIEVAL THREAD) ⤷  Start Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.